Spatial Genomics & Transcriptomics Market Share, Size, & Trends Analysis Report, Region, and Segment Forecasts, 2028

The global spatial genomics & transcriptomics market size is expected to reach USD 675.34 Million by 2028 at a CAGR of 18.1% over the forecast period, according to the latest report by Reports and Data. Key factors driving market revenue growth include increasing prevalence of genetic disorders and chronic conditions such as cancers, neurological disorders, and rare diseases, which have boosted need for high-resolution multiplex assays and instruments, and this is expected to further drive developments in spatial-based technologies. Increasing application of spatial genomics and transcriptomics for drug discovery and biomarker identification is also a key factor expected to drive revenue growth of market over the forecast period. Significant funding to expand R&D activities in the field of spatial-based technology is expected to support market growth going ahead.

Spatial transcriptomics covers methods specifically designed to assign cell types to their specific locations across tissue samples. It allows determination of subcellular localization of mRNA molecules. Data obtained about spatial distribution of mRNA molecules allows researchers to study cellular heterogeneity in tissues, tumors, and immune cells. Spatial-profiling based solutions allows analysis of tissue microenvironment, tumor biology, and tissues biomarkers. Spatial genomics and transcriptomics offers key insights in the fields of oncology, immunology, cell and gene therapy, histology, and embryology.

Get a sample of the report @

Technological advancements and rapid digitization have streamlined the daily operations of the pharmaceutical industry. Increasing spending on medicine due to growing geriatric populace, rising incidence of chronic diseases, increasing number of product launches, and growing number of R&D activities are some key factors contributing to revenue growth of the market. Increasing focus on patient engagement solutions, rising focus to cater to growing unmet clinical demand, adoption of advanced technologies to streamline workflows in healthcare sector, and availability of skilled healthcare professionals has been positively impacting the pharma & healthcare industry. The emergence of COVID-19 pandemic has further increased focus on healthcare facilities, teleconsultation and telemedicine, and increased burden on the healthcare industry compelling governments and companies to invest heavily to cater to the growing global demand.

Top Companies operating in the Market and Profiled in the Report include:

10X Genomics, NanoString Technologies Inc., Illumina Inc., Bio-Rad Laboratories, Natera Inc., S2 Genomics, Inc., Dovetail Genomics, Bio-Techne, Flagship Biosciences, Fluidigm Corporation, Seven Bridges Genomics, Horizon Discovery Group Plc., and Akoya Biosciences, Inc., among others.

Request a discount on the report @

Spatial Genomics & Transcriptomics Market Segmentation:

Technique Outlook (Revenue, USD Million; 2018-2028)

  • Spatial Genomics
    • Fluorescence In Situ Hybridization (FISH)
    • Sequencing Techniques
    • Others Spatial Genomics Analysis Techniques
  • Spatial Transcriptomics
    • Immunohistochemistry (IHC)
    • In Situ Hybridization
    • Sequencing Technologies
    • Microscopy-based RNA Imaging
    • Other Spatial Transcriptomics Techniques

Product Outlook (Revenue, USD Million; 2018-2028)

  • Instruments
  • Consumables
  • Software

Application Outlook (Revenue, USD Million; 2018-2028)

  • Translational Research
  • Drug Discovery & Development

End-user Outlook (Revenue, USD Million; 2018-2028)

  • Academic & Research Institutions
  • Contract Research Organizations (CROs)
  • Pharmaceutical and Biotech Companies
  • Others

To know more about the report @

The report discusses in detail the top companies in the market along with their recent initiatives such as mergers and acquisitions, joint venture, partnerships, corporate and government deals, collaborations, and brand promotions and product launches among others. The report further discusses the companies’ initiatives and investments in key regions across the globe such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Region analysis Covers:

  • North America (U.S.A., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of Europe)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

In conclusion, the report offers a comprehensive analysis of the factors expected to drive the global Spatial Genomics & Transcriptomics market growth over the forecast period of 2021-2028. The report is an all-inclusive document covering the market landscape and a futuristic perspective on its growth and progress. The report also provides an analysis of the entry-level driving and restraining factors for the new entrants contributing to the market. The report also offers strategic recommendations to the established players as well as new entrants to help them gain a strong foothold in the market.

Request a customization of the report @

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Read More Reports:-

Rheumatoid Arthritis Drugs Market @

Nuclear Medicine Imaging Market @

Explore More Reports From Different Publication:

Nerve Repair and Regeneration Market Sales

Nanoemulsions Market Suppliers




Back to top button